Showing results (131-140 of 434) with videos related to
Sort By:
Pageof 44
JAMA Internal Medicine|October 21, 2014
Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trialDavid A Fiellin, Richard S Schottenfeld, Christopher J Cutter, et al.Journal of Addiction Medicine|February 28, 2012
Human immunodeficiency virus testing practices among buprenorphine-prescribing physiciansE Jennifer Edelman, An T Dinh, Brent A Moore, et al.Journal of Addiction Medicine|August 10, 2016
The Availability of Ancillary Counseling in the Practices of Physicians Prescribing BuprenorphineDeclan T Barry, Tera Fazzino, Emily Necrason, et al.Drug and Alcohol Dependence|November 10, 2019
Accidental drug overdose deaths in Connecticut, 2012-2018: The rise of polysubstance detection?Taeho Greg Rhee, Joseph S Ross, Robert A Rosenheck, et al.Alcoholism, Clinical and Experimental Research|July 7, 2020
Safety of Gabapentin Prescribed for Any Indication in a Large Clinical Cohort of 571,718 US Veterans with and without Alcohol Use DisorderChristopher T Rentsch, Kenneth L Morford, David A Fiellin, et al.Addictive Behaviors|September 26, 2020
Developmental trajectory classes in psychological dysregulation predict later decision-making competenceJoshua A Weller, Andrew M Parker, Maureen Reynolds, et al.Drug and Alcohol Dependence|September 23, 2008
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patientsEmlyn S Jones, Brent A Moore, Jody L Sindelar, et al.Pain|April 23, 2013
Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic reviewWilliam C Becker, Liana Fraenkel, E Jennifer Edelman, et al.Journal of Substance Abuse Treatment|December 23, 2018
A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug useBrent A Moore, Frank D Buono, Daniel P Lloyd, et al.The American Journal of Managed Care|February 12, 2014
The effects of federal parity on substance use disorder treatmentSusan H Busch, Andrew J Epstein, Michael O Harhay, et al.Pageof 44